Cure
Overview
The dates, locations, costs, and what to expect from 13 major biopharma and life sciences events, from ASCO to J.P. Morgan.
The biopharma conference circuit is where deals get made, trial data lands, and investors find their next bet. Below are 13 of the most influential biopharma and life sciences events running from through May 2027, covering AI-enabled drug discovery, synthetic biology, precision medicine, translational research, commercialization strategy, and global biotech investing. Many include private partnering programs that extend well beyond the formal agenda.
ASCO Annual Meeting
Date: May 29-June 2, 2026
Location: Chicago, IL
Purpose: Clinical oncology data, translational cancer research, investor visibility, pharma partnering
Scale: Attracts 40,000+ oncology professionals, researchers, pharma executives, investors, and clinicians globally
Cost: Registration is about $255 to $1,935 depending on date registered, membership status, and classification ASCO Annual Meeting 2026 is a large, clinical oncology conference, where biotech and pharma companies present pivotal cancer trial data that can impact partnerships, valuations, and standards of care. With over 200 sessions, attendees can listen in on topics about desmocolin-3–directed immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma, targeting MAN1A1 to address immune checkpoint inhibitors resistance, and more.
The weekend includes 23 oral abstract sessions, 25 rapid oral abstract sessions, and 13 clinical science symposia, featuring over 450 oral abstract presentations. There will also be 15 case-based panels, featuring interactive audience polling and over 2,700 poster presentations, including trials in progress. There is also an opportunity to network with peers and experts at sessions with the option to use the Find a Colleague directory to search for registered attendees or presenters and send a direct, private email to connect with them.
World Orphan Drug Congress USA
Date: June 9-11, 2026
Location: Boston, MA
Purpose: Rare disease therapeutics, orphan drug development, regulatory and reimbursement strategy
Scale:2,000+ attendees from biotech, pharma, advocacy organizations, FDA/regulatory, and investors
Cost: Passes cost between $595 and $3,595 depending on access level and timing World Orphan Drug Congress USA 2026 focuses on rare disease drug development, orphan commercialization, patient engagement, and regulatory strategy. The meeting brings together biotech innovators, advocacy groups, regulators, and specialty pharma leaders. More than 280 speakers will present on topics like policies for health insurance coverage for rare disease and orphan drugs, venture capital for rare disease, pricing landscape for orphan drugs, and more. Key speakers include Laura Tadvalkar, Managing Director at RA Capital Management and Chris Garabedian, Portfolio Manager at Perceptive Advisors. Participants will have dedicated space on the expo floor to present their pipeline and network time designed to make connections with potential partners and investors.
DIA Global Annual Meeting
Date: June 14-18, 2026
Location: Philadelphia, PA
Purpose: Drug development, regulatory science, clinical operations, patient engagement
Scale: 4,100+ attendees from pharma, biotech, CROs, regulators, and academia
Cost: Registration costs at the time of publication are between $2,245 and $2,475 DIA Global Annual Meeting 2026 is a global life sciences conference focused on the full drug development lifecycle, including regulatory affairs, clinical development, safety, medical affairs, and patient engagement. Sessions on topics including transforming years of digital debt into an AI-ready content foundation, challenges in scaling up cloud-powered regulatory collaborations, how AI enabled authoring is transforming regulatory content development, delivering measurable improvements in speed, consistency, and quality across submissions, and more. Keynote speaker is David C. Fajgenbaum, immunologist, physician-scientist, author, and associate professor at the University of Pennsylvania, who transformed the treatment of Castleman disease after nearly dying from the illness himself.
BIO International Convention
Date: June 22-25, 2026
Location: San Diego, CA
Purpose: Partnering, licensing, venture capital, biotech business development, strategic collaborations
Scale:Approximately 21,500 industry leaders from around the world
Cost: Starts at $600 to $3,950 depending on membership, access, and date of registration BIO International Convention 2026 is a large biotechnology partnering conference bringing together biotech companies, pharmaceutical firms, venture capital, academic institutions, and government organizations. Offers business development and licensing opportunities. Attendees can choose from more than 135 sessions across 18 focus areas with discussions from leading biotechnology companies, investors, service providers, government officials, regulators and patient advocates. Topics include how technology is scaling cell and gene therapies, diversifying investments and the pipeline to accelerate progress in Alzheimer’s disease, breakthrough innovations driving global competitiveness, and more. Participants who purchase the Premier Access registration package get exclusive access to The BIO Partnering meeting-scheduling platform, which allows them to find potential partners, and schedule and accept meetings.
LSX USA Congress
Date: September 22-24, 2026
Location: Boston, MA
Purpose: Early- and mid-stage biotech fundraising, partnering, licensing, investor networking
Scale: 1,000+ senior attendees, 2,000+ partnering meetings, and 250+ investors
Cost: Registration ranges from $3,670 to $5,245; investors may receive free access if registered early LSX USA Congress is a biotech fundraising and partnering conference designed specifically to connect emerging and growth-stage life science companies with venture capital, private equity, and pharmaceutical business development leaders. Strong emphasis on curated 1:1 meetings and investment opportunities. Focused content includes early innovation and technology translation, capital markets and investment strategies, pharma partnering and deal making, and market opportunities and commercialization.
Key speakers include Scott DeWire, PhD, Corporate Senior Vice President and Global Head of Business Development & Licensing at Boehringer Ingelheim, Brian Goodman, Managing Director at Vida Ventures, Elena Diez Cecilia, Senior Director External Innovation DPDS at Johnson & Johnson, and more. Attendees can showcase their company to influential life science investors and pharma executives. Participants can also engage in speed networking with biotechs, pharmaceutical companies, investors, and industry leaders to seek funding, explore licensing opportunities, or build strategic alliances.
BioTechX USA
Date: September 29-30, 2026
Location: Boston, MA
Purpose: AI in drug discovery, genomics, precision medicine, digital transformation in pharma
Scale: Thousands of biotech, pharma, data science, and technology leaders and 1,500+ attendees
Cost: Fees range from $2,995 to $3,495 depending on access level and timing of registration BioTechX USA is a conference at the intersection of AI, genomics, precision medicine, diagnostics, and pharmaceutical innovation with focus on data-driven drug discovery and next-generation biotech technologies. Sessions include topics around digital transformation in biotherapeutics discovery, data science ecosystem for pharma R&D, digital innovations driving clinic trials efficiencies, and more.
Speakers include Catherine Brownstein, Assistant Professor at Harvard Medical School, Sarah Johnson, Partner at Advantary Capital Partners, Peter Marks, SVP Molecule Discovery and Head of Infectious Diseases at Eli Lilly, and more. Attendees can also attend the Interactive Poster Session, which is a showcase of the latest research, clinical innovation, and emerging developments in biotech from leading clinicians, researchers, and industry experts.
ASAP BioPharma Conference
Date: November 9-11, 2026
Location: Boston, MA
Purpose: Alliance management, pharma partnerships, collaboration strategy, business development
Scale: Hundreds of alliance and partnership professionals from biotech and pharma companies
Cost: Fees range from $1,839 to $2,699 depending on timing and type of registration ASAP BioPharma Conference 2026 is centered on strategic alliances, partnering, and collaboration management within the biopharma industry. Attendees include alliance managers, business development professionals, and pharma partnership leaders. Participants can sign up for all-day ASAP courses, developed by alliance leaders for alliance leaders, and earn 12 PD credit hours toward CA-AM and CSAP certification renewal. Featured speakers include Katherine Kendrick, CSAP, CA-AM, Executive Director & Head of Alliance Management at Jazz Pharmaceuticals; Arne Wörn, PhD, Global Head of Alliance Management at Novartis.
J.P. Morgan Healthcare Conference
Date: January 11-14, 2027
Location: San Francisco, CA
Purpose: Invite-only event connecting companies, investors, and healthcare leaders
Scale: ~9,500 attendees at the 2026 conference
Cost: Not applicable J.P. Morgan Healthcare Conference 2027 is an influential healthcare investment conference globally, bringing together major pharmaceutical companies, biotech firms, investors, analysts, and healthcare executives. The event is famous for major deal announcements and strategic meetings. Attendees are primarily invitation-based. Public Company sessions are typically 40 minutes long and include a Q&A.
Because the main event is invite-only, many founders and operators travel to the area for the surrounding satellite meetings and off-site gatherings. These events offer opportunities to connect with investors, partners, and peers who are already in town, making the week valuable even without direct access to the core conference.
Companies that attended in the past include Bristol-Myers Squibb, Dexcom, Grail, Scholar Rock Holding Corp, BridgeBio Pharma Inc, and Johnson & Johnson.
Advanced Therapies Week
Date: January 18-21, 2027
Location: San Diego, CA
Purpose: Cell and gene therapy innovation, partnering, manufacturing, investment, commercialization
Scale: 1,800+ attendees including cell & gene therapy developers, investors, and regulators
Cost:2027 presale open now with opportunity to win accommodation + 2× VIP tickets (valued at $8,000) Advanced Therapies Week 2027 focuses on cell therapy, gene therapy, regenerative medicine, and advanced biologics. The event combines scientific innovation with manufacturing, commercialization, and investor partnering opportunities. Workshops include topics like advancing CAR-T Cell Therapy workflows with novel cell selection and non-viral delivery and how automated flow cytometry can support efficient, compliant in-process testing within cell and gene therapy manufacturing. The event includes the Poster Zone on the show floor, which is a curated showcase of the most exciting research, case studies, and breakthrough projects across cell and gene therapy.
Reuters Pharma USA
Date: March 10-11, 2027
Location: Philadelphia, PA
Purpose: Pharma strategy, commercialization, digital health, market access, patient engagement
Scale: Senior pharma executives, commercial leaders, patient strategy teams, and technology providers
Cost: Approximately $2,500 Reuters Pharma USA 2026 is a pharmaceutical leadership conference focused on commercial strategy, market access, patient engagement, digital transformation, and the future of the pharmaceutical industry. Features more than 20 interactive sessions, 170 speakers, and 32 in-depth case studies. Attendees can participate in more than eight hours of networking with senior leaders at the event including at the exhibit hall and networking zone.
BioProcess International US West
Date: March 16-17, 2027
Location: San Diego, CA
Purpose: Biomanufacturing, biologics production, process development, CMC, scale-up strategy
Scale: 800+ scientists, executives, and technology leaders across all phases of bioprocessing
Cost: $2,799 to $3,299 BioProcess International US West 2027 is a bioprocessing and manufacturing conference focused on biologics scale-up, CMC strategy, process development, and next-generation manufacturing technologies. Themes covered include digitalization of production processes, the application of AI and machine learning, advanced upstream and downstream technologies, cell culture techniques, purification of biological products, and innovations in analytics, quality control, and cell and gene therapies. Exhibits showcase things like recombinant proteins and monoclonal antibodies (mAbs) and solutions in cell- and gene-based therapies.
AACR Annual Meeting
Date: April 2–7, 2027
Location: Orlando, FL
Purpose: Cancer research, translational oncology, drug discovery, emerging therapeutics
Scale: More than 23,000 registrants from 74 countries and territories participated in the 2026 meeting
Cost: Depends on membership status, income, and package purchased, but can range from $35-$1,895 AACR Annual Meeting 2027 is a cancer research meeting showcasing cutting-edge discoveries in oncology, translational medicine, and experimental therapeutics. Widely attended by biotech innovators and pharma oncology teams. The meeting highlights the work of acclaimed scientists in cancer research from institutions across the globe and focuses on population science and prevention, cancer biology, translational and clinical studies, survivorship, and advocacy.
Festival of Biologics USA
Date: April 13-14, 2027
Location: Boston, MA
Purpose: Biologics R&D, antibody therapeutics, immunotherapy, manufacturing, commercialization
Scale:2,000+ attendees across biotech, pharma, and biologics manufacturing sectors
Cost: $1,495 to $3,995; but significant group discounts are available Festival of Biologics USA is a biologics-focused conference covering the full lifecycle of biologic therapeutics from discovery and translational science through clinical development and manufacturing. Includes antibodies, immunotherapy, biosimilars, and cell therapy. The agenda covers development, clinical trials operations, manufacturing, finance and investment, commercialization and market access, and more. Some speakers include Jakub Tomala, Assistant Research Professor at John Hopkins University; Yu Tian, Director at AbbVie; Liviu Movileanu,Professor at Syracuse University; and more.
